{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-142037","form_type":"8-K/A","ticker":"FATE","cik":"0001434316","company_name":"FATE THERAPEUTICS INC","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.282543+00:00","generated_at":"2026-05-19T04:30:47.854318+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Fate Therapeutics board sets annual say-on-pay votes after stockholder advisory approval","bullets":["Stockholders approved advisory vote on executive compensation every one year.","Board determined to hold non-binding say-on-pay votes annually.","Next frequency vote required no later than 2031 annual meeting.","No other changes from original May 30, 2025 8-K reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-142037","json":"https://secwatch.observer/filing/0001193125-25-142037.json","markdown":"https://secwatch.observer/filing/0001193125-25-142037.md","text":"https://secwatch.observer/filing/0001193125-25-142037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/0001193125-25-142037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/d35713d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T04:30:47.854318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}